RIPE-KG · Version 1.1.0 · Resource

ripekg:author/RIPEAU509569B11F48B99D

https://w3id.org/ripe/ripe-kg/author/RIPEAU509569B11F48B99D
SubjectPredicateObject
ripekg:author/RIPEAU509569B11F48B99DAbbas Taghavi Ardakani rdf:type node1
ripekg:author/RIPEAU509569B11F48B99DAbbas Taghavi Ardakani rdf:type rdfs:Resource
ripekg:author/RIPEAU509569B11F48B99DAbbas Taghavi Ardakani rdf:type owl:Thing
ripekg:author/RIPEAU509569B11F48B99DAbbas Taghavi Ardakani rdf:type prov:Person
ripekg:author/RIPEAU509569B11F48B99DAbbas Taghavi Ardakani rdf:type foaf:Person
ripekg:author/RIPEAU509569B11F48B99DAbbas Taghavi Ardakani rdf:type ripe:AuthorAuthor
ripekg:author/RIPEAU509569B11F48B99DAbbas Taghavi Ardakani owl:sameAs https://semopenalex.org/author/A5034438179
ripekg:author/RIPEAU509569B11F48B99DAbbas Taghavi Ardakani foaf:familyName Taghavi Ardakani
ripekg:author/RIPEAU509569B11F48B99DAbbas Taghavi Ardakani foaf:givenName Abbas
ripekg:author/RIPEAU509569B11F48B99DAbbas Taghavi Ardakani foaf:name Abbas Taghavi Ardakani
ripekg:work/10.1111%2Fpai.12978EXPRESSION OF CONCERN: The effects of melatonin administration on disease severity and sleep quality in children with atopic dermatitis: A randomized, double‐blinded, placebo‐controlled trial dcterms:creator ripekg:author/RIPEAU509569B11F48B99DAbbas Taghavi Ardakani